喘,药物使用和青少年的牙:一个基于人口的研究
Caries research
|July 24, 2025
概括
这项研究没有发现喘,喘药物使用和青少年牙之间的联系. 这些发现表明,喘管理不会增加永久牙中牙的风险.
科学领域:
- 口腔健康研究研究 口腔健康研究
- 儿童喘 在儿童喘中
- 流行病学 流行病学
背景情况:
- 喘和牙损伤共享潜在的风险因素,如口腔呼吸和吸入药物.
- 现有的研究对喘,喘治疗及其牙损伤风险之间的关联是不确定的.
研究的目的:
- 为了调查喘,发病年龄,药物使用和13岁青少年牙损伤经验之间的联系.
- 澄清大量青少年队列中喘管理和口腔健康结果之间的关系.
主要方法:
- 利用了来自前性,基于人口的R世代研究的数据.
- 通过家长问卷收集喘和药物数据;使用腐烂,缺失和填充牙指数 (DMFT) 评估牙损伤.
- 使用障碍负二项式回归模型来分析关联.
主要成果:
- 这项研究包括3356名青少年 (13.6±0.34岁;48.8%男性).
- 牙损伤的发病率为35.2%;喘的发病率为15.3%.
- 在喘,发病年龄或药物使用与牙损伤风险之间没有发现显著的关联.
结论:
- 这项大规模的青少年研究发现,喘或其药物与牙损伤之间没有联系.
- 这些发现与其他大型队列研究一致,加强了证据基础.
- 目前的喘管理策略似乎没有提高牙变的风险.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Antiasthma Drugs: β2-Adrenoceptor Agonists
389
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
389
Antiasthma Drugs: Methylxanthines
408
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
408


